Oct 13, 2026 06:51AM
Oct 8, 2026 04:06PM
Aug 10, 2026 04:56PM
Jul 23, 2026 06:06AM
Jun 30, 2026 06:45AM
May 12, 2026 05:03PM
Apr 16, 2026 08:50AM Palisade Bio abstract selected for poster at DDW 2026 conference
Apr 13, 2026 07:39AM
Mar 31, 2026 04:46PM
Mar 31, 2026 07:35AM
Feb 24, 2026 04:07PM
Feb 23, 2026 08:40AM
Jan 9, 2026 01:08AM
Jan 7, 2026 08:17AM Palisade Bio secures $500,000 investment from Crohn's foundation
Dec 30, 2025 08:35AM
Dec 29, 2025 04:07PM
Dec 29, 2025 03:39AM
Dec 2, 2025 08:45AM
Oct 13, 2025 08:46AM
Sep 29, 2025 06:47AM
Sep 26, 2025 04:05PM Palisade Bio adjourns stockholder meeting due to lack of quorum
Aug 15, 2025 04:09PM
Jul 22, 2025 08:40AM
Jul 9, 2025 08:45AM
May 27, 2025 08:33AM
May 6, 2025 08:32AM
Apr 9, 2025 08:31AM
Mar 12, 2025 08:32AM Palisade Bio Inc. (PALI) Announces Two Abstracts Selected to be Showcased as Poster of Distinction and Poster Presentation
Feb 20, 2025 08:46AM
Feb 10, 2025 08:45AM
Jan 16, 2025 08:03AM
Dec 17, 2024 08:34AM
Dec 12, 2024 12:08PM
Nov 12, 2024 04:48PM
Nov 7, 2024 08:31AM Palisade Bio Inc. (PALI) Announces First Subject Dosed in Phase 1 Clinical Study of PALI-2108 for the Treatment of Moderate-to-Severe Ulcerative Colitis
Oct 31, 2024 08:33AM
Oct 30, 2024 06:10AM
Oct 10, 2024 08:32AM
Sep 25, 2024 08:01AM
Sep 5, 2024 08:01AM
Aug 13, 2024 10:35AM
Aug 8, 2024 08:00AM Palisade Bio (PALI) Selects Dose for Upcoming Phase 1 Clinical Study of PALI-2108 for Ulcerative Colitis
Jul 29, 2024 09:08AM
Jul 19, 2024 08:32AM
Jul 11, 2024 08:05AM
Jun 21, 2024 08:15AM
Jun 11, 2024 08:34AM

479,030 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All